Interpace Diagnostics Group Financial Overview
Interpace Diagnostics Group's market cap is currently $6.20M. The company's EPS TTM is $0.033; its P/E ratio is 4.33; Interpace Diagnostics Group is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
